Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

LGO — Predicate Candidate Screening

5 FDA 510(k) clearances under this product code; the 50 most recent screened below.

155 daysmedian FDA review time
283 days90th percentile
5clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K894947PLATELIA TOXO IGG KITKallestad Diag, A Div. of Erbamont, Inc.1990-03-232320
K874544SNAP(R) CAMPYLOBACTER CULTURE IDENT DIAGNOSTIC KITMolecular Biosystems, Inc.1988-08-122830
K791118HLA CONTROL SERACalbiochem-Behring Corp.1979-08-03490
K761008LYMPHOCYTE TYPING, NEGATIVE CONTROLHyland Therapeutic Div., Travenol Laboratories1977-04-061550
K761009LYMPHOCYTE TYPING, POSITIVE CONTROLHyland Therapeutic Div., Travenol Laboratories1977-04-061550

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda